NCT01125722 Clinical Trial to Study a Non-invasive Neurostimulation Device on Urgency (Urinary) Incontinence Overactive Bladder (OAB) Status COMPLETED Phase NA
NCT01122563 A Study to Evaluate Response of Overactive Bladder Symptom Score (OABSS) to Treatment Status COMPLETED Phase N/A
NCT01122550 Reproducibility Study of Overactive Bladder Symptom Score [OABSS] Status COMPLETED Phase N/A
NCT01093534 Study of 2 Doses of Solifenacin Succinate in Female Subjects With Overactive Bladder. Status COMPLETED Phase PHASE4
NCT01089751 Efficacy of Sanctura XR (Trospium Chloride) for Reducing Overactive Bladder Symptoms in Female Subjects Refractory to Detrol LA (Tolterodine Tartrate Extended Release) Daily Status COMPLETED Phase PHASE4
NCT01047046 Combined Anticholinergic Medication and Sacral Neuromodulation to Treat Refractory Overactive Bladder Status COMPLETED Phase N/A
NCT01004315 A Confirmatory Study of KUC-7483 in Patients With Overactive Bladder Status COMPLETED Phase PHASE3
NCT01003405 Long-term Safety and Efficacy of KUC-7483 in Patients With Overactive Bladder Status WITHDRAWN Phase PHASE3
NCT01003249 Dysfunctional Voiding and Lower Urinary Tract Symptoms With Baclofen Status TERMINATED Phase PHASE4
NCT00985387 Evaluation of Adherence to Solifenacin Treatment in Overactive Bladder Patients Status COMPLETED Phase N/A
NCT00979472 Solifenacin Flexible Dosing Study in Frequent Micturition Patients With and Without Urgency Status COMPLETED Phase PHASE4
NCT00943904 Comparison of Motor and Sensory Response With Interstim Stimulation Status COMPLETED Phase NA
NCT00943735 This Is An Open-Label Study To Evaluate Fesoterodine Plus "Your Way" Patient Support Plan In Patients With Symptoms Of Overactive Bladder Status COMPLETED Phase N/A
NCT00932022 Trospium Chloride XR in Obese Female Patients With Overactive Bladder Status COMPLETED Phase PHASE4
NCT00928070 A Study Of Efficacy And Safety Of Fesoterodine In Vulnerable Elderly Subjects With Overactive Bladder Status COMPLETED Phase PHASE4
NCT00922506 Combination Treatment With Doxazosin Plus TolterodineSR 2 mg Versus 4mg in Men With an Overactive Bladder (OAB) and Benign Prostatic Hyperplasia (BPH) Status COMPLETED Phase PHASE4